No Difference Seen In Fatality Rate With New Strain Of Coron
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Case fatality and hospitalisation rate from a new strain of coronavirus spreading rapidly in the UK and elsewhere is no different than that from other strains that do not carry this mutation, a preliminary study by Public Health England showed.

Preliminary results from the cohort study found no statistically significant difference in hospitalisation and 28-day case fatality between cases with the variant of concern (VOC) and wild-type comparator cases, said authors of the study led by Meera Chand of Public Health England. “There was also no significant difference in the likelihood of reinfection between variant cases and the comparator group.”

The preliminary study on the impact of the new mutation of the SARS-Cov-2 in severity of the disease said majority of the cases found of this variant came from residents in private dwellings, and the variant cases were most likely to be part of residential cluster.

India genome sequencing

The Union well being ministry stated it will likely be finishing up genome sequencing of all worldwide travellers to the nation in the previous fortnight if symptomatic and tested positive to widen the scope of its scrutiny for the new, infectious strain of SARS-Cov-2 that’s stated to have originated in the United Kingdom.

Additionally, the ministry has additionally proposed that 5% of constructive samples from every district/state detected every day are despatched for genome sequencing, irrespective of journey historical past.